GSK, Moderna settle patent dispute over Moderna COVID, RSV shots

British drugmaker GSK has settled lawsuits that accused Moderna's COVID-19 vaccines Spikevax and ​mNEXSPIKE and RSV shot mResvia of infringing ‌its patents, the companies said on…

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)